| Clinical Characteristics | Number of studies included (papers) | Tests for heterogeneity | Effect of the model | Results of meta-analysis | I2 (%) | P value | OR (95%CI) | value |
| Age | 39 [5, 10, 16–52] | 66.5% | <0.001 | Random | 1.07 (0.96, 1.19) | 0.253 | Gender | 42 [5, 10, 16–55] | 0.0% | 0.66 | Fixed | 1.03 (0.92,1.15) | 0.648 | Tumor size | 33 [10, 16, 29, 31, 34, 36, 39, 41–52] | 71.8% | <0.001 | Random | 2.28 (2.00,2.60) | <0.001 | HBV infection | 25 [10, 16, 19, 20, 24, 25, 27, 29, 31, 34, 36, 39, 41, 43, 44, 46, 52, 55] | 0.0% | 0.712 | Fixed | 1.12 (0.95,1.31) | 0.182 | Liver cirrhosis | 18 [16, 20, 22, 25, 34, 38, 42, 44, 47, 49, 51, 55] | 0.0% | 0.799 | Fixed | 1.39 (1.16,1.66) | <0.001 | Metastasis | 16 [22, 23, 27, 28, 30, 34, 37, 38, 40, 41, 48, 51, 52] | 72.5% | <0.001 | Random | 1.80 (1.49,2.18) | <0.001 | H- grade | 28 [5, 10, 16, 25, 28, 30, 32, 33, 35, 37, 39, 41, 42, 45, 48, 53, 54] | 67.5% | <0.001 | Random | 0.54 (0.48,0.62) | <0.001 | AFP (400) | 18 [10, 16, 22, 24, 26, 35, 36, 41, 45, 47, 51, 52, 55] | 41.5% | 0.034 | Fixed | 1.46 (1.22,1.75) | <0.001 | AFP (20) | 9 [27, 29, 40, 42, 43, 46, 48, 50] | 76.9% | <0.001 | Random | 1.79 (1.40,2.29) | <0.001 | TNM stage | 33 [5, 10, 15, 20, 22, 24, 34, 36, 43, 46, 48, 50, 51, 54] | 78.9% | <0.001 | Random | 0.46 (0.41,0.51) | <0.001 | Tumor number | 25 [10, 16, 24, 26, 29, 31, 34, 35, 37, 42, 43, 46, 48, 50, 51, 55] | 53.4% | 0.001 | Random | 0.72 (0.62,0.84) | <0.001 | V-invasion | 22 [16, 19, 24, 26, 30, 32, 35, 37, 41, 42, 44, 45, 47, 49, 51, 55] | 84.7% | <0.001 | Random | 2.02 (1.74,2.35) | <0.001 |
|
|